Life Science Investing Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
Life Science Investing Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
Life Science Investing Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis Program
Life Science Investing Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress
Goldgroup Enters Into Agreement To Sell Subsidiary Minera Apolo, S.A. de C.V., Disposing of Pinos Project
55 North Mining Appoints Wayne Parsons as Executive Chair; Strengthens Leadership as the Company Advances the Last Hope Gold Project
